gastroenterologists-2018-keynote

2 / 2

Page 8
Notes:
allied
academies
Nov 15-16, 2018 | Paris, France
Gastroenterology and Digestive Disorders
International Conference on
Journal of Gastroenterology and Digestive Diseases | Volume 3
The time has come where imaging biomarkers are gaining
acceptance beyond Oncology. This session will cover the
creation of a Virtual Liver Biopsy as part of a Digital Physical
Exam to directly measure major vital organs & tissues, from a
whole-body perspective, based on non-invasive imaging for a
wide range of conditions and diseases beyond Oncology.
With increasing focus on genomic, metabolomic, andmolecular
quantification of the human body for use in precision medicine,
the development of diagnostics, therapeutics, and monitoring
of disease progression/treatment takes on a greater role for
more effective outcomes. The majority of advances have not
included the phenotype, or observable characteristics of an
individual resulting from the interaction of its genotype with
the Environment.
Biomarkers provide researchers and clinicians with useful
measurements that allow for earlier diagnosis before a patient
begins to show signs of symptoms, and also quantitatively
show that a treatment is performing effectively. Technology is
now available to measure multiple vital organs & tissues for an
integrated exam using non-invasive imaging to acquire data,
automation algorithms to quantify images, & AI to develop
predictive analytics. A Software-as-a-Service platform enables
scalable access to the latest imaging technology, and support
for legacy scanners, while improving accuracy, precision, and
standardization across imaging facilities.
Speaker Biography
Mark Punyanitya is a Biomedical Engineer with advanced degrees in Applied Physiology &
Applied Clinical Trials. With 20+ years of experience overseeing global, multi-center clinical
trials for academic, biotech, & pharma sponsors, Mark has published over 44 papers & his
advances in body composition have been applied to a wide range of therapeutic areas. As a
Biomedical Engineer, Mark facilitates the translation of science, technology, &medicine for
the development & commercialization of quantitative imaging biomarkers.
Mark is Founder, President, & CEO of the Image Reading Center, Inc., an Imaging Core
Laboratory & Contract Research Organization for Clinical Trials, and Co-Founder, President,
& CEO of Pheno Mx, Inc., creating a Digital Physical Examination for the commercialization
of Imaging Biomarkers & Body Analytics.
e:
Mark Punyanitya
New York University, USA
The virtual liver biopsy: A component of the digital physical exam for personalized
medicine